tirzepatide glp-1 gip Main physiological actions of the dual and agonist GLP-1 + GIP Injections -

Key points: GI side effects are most common: nausea, diarrhea, and decreased appetite They usually improve: most patients adapt within 4-8 weeks Start low, go slow: the escalation schedule exists for a reason Stay hydrated and modify your diet: simple changes make a big difference Communicate with your provider: don't suffer unnecessarily Sources SURMOUNT-1 Clinical Trial (Jastreboff et al., NEJM 2022) SURPASS-1 Clinical Trial (Rosenstock et al., NEJM 2021) Mounjaro Prescribing Information, Eli Lilly Zepbound Prescribing Information, Eli Lilly Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice

Since retatrutide is not available as a pharmaceutical product, all current formulations are research-grade and require reconstitution

[DOI] [PubMed] [Google Scholar] 97.Lorenz M., Pfeiffer C., Steinstrsser A., et al

Both groups ultimately achieved clinically meaningful results, but the trajectory differed

Because every clients dosing journey is unique, our Tirzepatide pricing is based on both concentration level and length of commitment, allowing you to select the plan that best fits your goals and pace of progress